Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Gene ; 343(1): 143-51, 2004 Dec 08.
Artículo en Inglés | MEDLINE | ID: mdl-15563840

RESUMEN

Calcitonin inhibits bone resorption by acting on osteoclasts via a specific receptor. The calcitonin receptor (CTR) is also found in many other normal and malignant tissues and cell lines. It has been cloned and sequenced in several species including humans. It belongs to a subclass of seven-transmembrane G protein-coupled receptors. Four human CTR (H-CTR) isoforms generated by alternatively spliced mRNA have previously been described. Two H-CTR encoding DNAs containing an unidentified 50-bp insert are now reported from T47D cells. The 50-bp insert corresponds to a DNA region located between exon 9 and exon 10, and appears to originate from an alternative splicing process. The two H-CTR cDNAs encode 274 and 290 aa long isoforms. Both are deleted from the putative fourth transmembrane domain to C-tail. They differ by the presence (H-CTR5) or absence (H-CTR6) of a previously known 16-aa insert in the putative first intracellular loop. Cell- and tissue-distribution analysis using RT-PCR demonstrates that the shorter one, HCTR6, is more prevalent. The mRNA of both isoforms was detected in giant cell tumor, whereas only H-CTR6 mRNA was detected in TT cells and kidney tissue. Neither H-CTR5 nor H-CTR6 could be detected in peripheral blood mononuclear cells cultured in the presence of RANKL, in MCF7 cells, and in cortical brain and ovarian tissues. When H-CTR6 was transiently expressed in HEK293 cells, CT failed to induce production of cAMP or to bind to the receptor. These suggest either an intrinsic loss of ligand binding function, or an altered intracellular trafficking. Our findings therefore indicate the existence of two novel splice variants of the H-CTR and confirm that multiple splicing patterns could be involved in the post-transcriptional regulation of the gene.


Asunto(s)
Receptores de Calcitonina/genética , Empalme Alternativo , Secuencia de Aminoácidos , Sustitución de Aminoácidos , Secuencia de Bases , Calcitonina/metabolismo , Línea Celular , Clonación Molecular , Cartilla de ADN , Exones/genética , Humanos , Cinética , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Isoformas de Proteínas/genética , Procesamiento Postranscripcional del ARN , Receptores de Calcitonina/química , Receptores de Calcitonina/metabolismo , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo
2.
FEBS Lett ; 167(1): 93-7, 1984 Feb 13.
Artículo en Inglés | MEDLINE | ID: mdl-6546550

RESUMEN

DNA complementary to mRNA extracted from the thyroid glands of patients suffering from medullary carcinoma of the thyroid (MCT), a calcitonin-producing tumour, was inserted in the Pst site of pBR 322 by G-C tailing. The recombinant plasmids were used to transform Escherichia coli DP 50. Ampicillin-resistant clones were screened using a 32P-labelled cDNA to mRNA extracted from a case of MCT particularly rich in calcitonin (CT) mRNA. Positive clones were subsequently rescreened using a 32P poly(T) probe. Eighty clones were thus purified, and the inserts obtained by digestion with PstI were subjected to positive hybridization selection with subsequent translation in vitro. An insert stimulating synthesis of the protein and containing restriction sites compatible with the previously published complete sequence of calcitonin mRNA from rat was sequenced. This cDNA insert contained the entire coding region of 426 bp, 70 bp at the 5'-end, and 295 bp upstream from the poly(A) tail. The complete amino acid sequence of human preprocalcitonin could thus be deduced.


Asunto(s)
Calcitonina/análisis , Precursores de Proteínas/análisis , Secuencia de Aminoácidos , Animales , Secuencia de Bases , ADN/análisis , Humanos , Plásmidos , ARN Mensajero/análisis , Glándula Tiroides/análisis , Neoplasias de la Tiroides/análisis
3.
Mol Gen Genet ; 182(3): 456-61, 1981.
Artículo en Inglés | MEDLINE | ID: mdl-6272062

RESUMEN

The lysA gene of Escherichia coli has been cloned from a lambda transducing phage on various plasmids, present in different copy numbers in bacterial cells. Synthesis of the product of this gene, diaminopimelate (DAP)-decarboxylase, and its regulation have been studied. Expression does not follow a simple gene dosage effect, maximal expression already being obtained with a six-copy plasmid. This result suggests that either a positive or an autogenous regulatory mechanism is involved. We also used one of the hybrid plasmids to look for expression of the bacterial lysA gene in Saccharomyces cerevisiae. The results indicate that the product of the E. coli gene is not actively translated in yeast.


Asunto(s)
Proteínas Bacterianas , Carboxiliasas/genética , Escherichia coli/genética , Lisina/genética , Plásmidos , Saccharomyces cerevisiae/genética , Bacteriófago lambda/genética , Regulación de la Expresión Génica , Genes Bacterianos , Vectores Genéticos , Operón , Especificidad de la Especie
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA